Healthways Inc. (NASDAQ:HWAY) shares reached a new 52-week high during trading on Thursday . The stock traded as high as $17.47 and last traded at $16.24, with a volume of 4,985,348 shares. The stock had previously closed at $12.18.

HWAY has been the topic of several recent analyst reports. FBR & Co reaffirmed a “buy” rating on shares of Healthways in a research note on Friday, April 29th. Barrington Research reaffirmed a “buy” rating on shares of Healthways in a research note on Saturday, April 30th. Zacks Investment Research raised shares of Healthways from a “sell” rating to a “hold” rating in a research note on Tuesday, May 3rd. Finally, Jefferies Group reiterated a “hold” rating and set a $13.00 target price on shares of Healthways in a report on Tuesday, May 3rd. One research analyst has rated the stock with a sell rating, two have issued a hold rating and two have given a buy rating to the company. The company has a consensus rating of “Hold” and a consensus price target of $13.40.

The firm’s market cap is $608.60 million. The stock has a 50-day moving average of $12.22 and a 200 day moving average of $11.55.

Healthways (NASDAQ:HWAY) last announced its quarterly earnings results on Thursday, April 28th. The company reported ($0.08) earnings per share for the quarter, missing the consensus estimate of ($0.02) by $0.06. During the same quarter last year, the firm posted ($0.05) earnings per share. The firm had revenue of $189.20 million for the quarter, compared to analysts’ expectations of $185.68 million. The company’s revenue was down .4% on a year-over-year basis. On average, equities analysts anticipate that Healthways Inc. will post $0.24 earnings per share for the current year.

Several hedge funds and institutional investors have recently made changes to their positions in HWAY. BNP Paribas Arbitrage SA boosted its position in shares of Healthways by 37.1% in the fourth quarter. BNP Paribas Arbitrage SA now owns 80,127 shares of the company’s stock valued at $1,031,000 after buying an additional 21,702 shares during the last quarter. American Capital Management Inc. boosted its position in shares of Healthways by 4.0% in the fourth quarter. American Capital Management Inc. now owns 896,380 shares of the company’s stock valued at $11,536,000 after buying an additional 34,590 shares during the last quarter. Finally, Royce & Associates LLC boosted its position in shares of Healthways by 25.2% in the fourth quarter. Royce & Associates LLC now owns 796,704 shares of the company’s stock valued at $10,254,000 after buying an additional 160,500 shares during the last quarter.

Healthways, Inc (Healthways) provides network delivered solutions and population health management services that are designed to help people manage their wellbeing, thereby managing their health and productivity, and their health-related costs. The Company operates in the domestic and international segments, which are collectively known as the well-being improvement services segment.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.